Hepatology Highlights
Zaid H. Tafesh, Robert S. Brown, Nicholas Russo, Russell Rosenblatt, Aleksey Novikov, Robert E. Schwartz, Joseph F. Pisa, Nicole T. Shen, Vikas Gupta, Shirley Cohen‐Mekelburg – 10 August 2018
Table of contents
10 August 2018
Hepatology Highlights
Zaid H. Tafesh, Robert S. Brown, Nicholas Russo, Russell Rosenblatt, Aleksey Novikov, Robert E. Schwartz, Joseph F. Pisa, Nicole T. Shen, Vikas Gupta, Shirley Cohen‐Mekelburg – 10 August 2018
Correction
10 August 2018
Cover Image
10 August 2018
Notices
10 August 2018
Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis
Uchenna Agbim, Yu Jiang, Satish K. Kedia, Ashwani K. Singal, Aijaz Ahmed, Kalyan Ram Bhamidimarri, David E. Bernstein, Stephen A. Harrison, Zobair M. Younossi, Sanjaya K. Satapathy – 9 August 2018 – Nonalcoholic fatty liver disease is an increasingly prevalent condition, and its more severe progressive state, nonalcoholic steatohepatitis (NASH), is currently the second most common indication for wait‐listed adults in the United States.
Primary Biliary Cholangitis Guidance Update: Implications for Liver Transplantation
Cynthia Levy – 9 August 2018
Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment
Amédée Renand, Sarah Habes, Jean‐François Mosnier, Hélène Aublé, Jean‐Paul Judor, Nicolas Vince, Philippe Hulin, Steven Nedellec, Sylvie Métairie, Isabelle Archambeaud, Sophie Brouard, Jérôme Gournay, Sophie Conchon – 6 August 2018 – Autoimmune hepatitis (AIH) is a rare disease characterized by an immune attack of the liver. This study consists of a comprehensive analysis of immune alterations related to AIH at diagnosis, and during remission phase under treatment.